![]() The foundation’s Child Apraxia Treatment program provides resources to both parents and clinicians on evidence-based assessment and treatment of CAS, including the DTTC treatment method. It supports a wide range of organizations including those that provide arts and humanities, community affairs, health and medicine, human services, and education benefits to members of the community. The Once Upon a Time Foundation is a $250 million private foundation based in Fort Worth, Texas. Elizabeth Murray, director of Remarkable Speech and Movement. Donna Thomas, lecturer at the University of Sydney and Dr. Shelley Velleman, professor at the University of Vermont and co-investigators Dr. Maria Grigos, associate professor at New York University Dr. Julie Case, assistant professor at Hofstra University Dr. Iuzzini-Seigel is the lead principal investigator on the project, working with co-PIs Dr. “This much needed research could have a lasting impact on the treatment process for children coping with CAS and lead to long-standing change in treatment delivery.” ![]() ![]() William Cullinan, dean of the College of Health Sciences. Iuzzini-Seigel, as this award is recognition of her research and scholarship on CAS,” said Dr. “We look forward to seeing which condition shows better efficacy,” Iuzzini-Seigel added. This two-year study will examine the impact of DTTC on 60 children with CAS when dose frequency is varied between groups. to increase clinical uptake of the treatment. Treatment will be conducted by clinicians throughout the U.S. ![]() This grant will fund a multisite phase II randomized control trial that will document the outcomes of DTTC in young children with CAS who are between 30 months and seven years of age. Over time and with extensive practice, the child will become more independent, and the therapist will fade these supportive cues. Initially the therapist provides substantial cueing (e.g., having the child produce the word simultaneously with the therapist while the child watches the therapist’s mouth). This study will compare treatment outcomes when DTTC - or Dynamic Temporal and Tactile Cueing - is provided twice a week for 12 weeks versus four times per week for six weeks.”ĭTTC is one motor-based speech treatment where the therapist selects specific word targets and helps the child to produce these words accurately and consistently over time using a cueing hierarchy. While it seems intuitive to predict that more frequent treatment would result in greater treatment gains than less frequent treatment, even at the same total dosage, empirical research is needed. “There is a lack of sufficient evidence to guide decision-making regarding treatment distribution. “There are few motor-based treatments for childhood apraxia of speech and there is a strong need for research that demonstrates their efficacy in large samples of children when different treatment parameters are varied,” Iuzzini-Seigel said. Children with CAS will often require years of intense targeted treatment to improve the clarity and naturalness of their speech. This often results in highly unintelligible speech, even though the child knows what they want to say. Jenya Iuzzini-Seigel, assistant professor of speech pathology and audiology in Marquette University’s College of Health Sciences, has been awarded a $1,156,000 grant from the Once Upon a Time Foundation for a randomized control trial that compares different treatment delivery schedules for children with childhood apraxia of speech.ĬAS is a neurological speech disorder in which a child has difficulty planning and programming speech movements.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |